Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail
-

L. Perrigo Company Close out Letter 5/9/11

   

Department of Health and Human Services logoDepartment of Health and Human Services

 Public Health Service
Food and Drug Administration
 

Detroit District
300 River Place

Suite 5900
Detroit, MI 48207
Telephone: 313-393-8100
FAX: 313-393-8139 

VIA UPS


May 9, 2011


Mr. Joseph C. Papa
President and Chief Executive Officer
L. Perrigo Company

515 Eastern Avenue

Allegan, Michigan 49010
 

Dear Mr. Papa:


The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter 2010-DT-11, dated April 29, 2010. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.


This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.


Sincerely,

/S/
Cicely N. Vaughn
Compliance Officer

Detroit District Office
 

-
-